Source comparison
BPC-157 Research REM Sleep Considerations: Data Comparison
University of Zagreb rodent stress model (2019) 10 mcg/kg daily × 14 days +19% total REM duration; −8.3 min REM latency No change in total sleep time or fragmentation index EEG telemetry Most robust sleep architecture data available. Demonstrates selective REM
This comparison does not assign a generated winner or score.
- University of Zagreb rodent stress model (2019)
- 10 mcg/kg daily × 14 days
- +19% total REM duration; −8.3 min REM latency
- No change in total sleep time or fragmentation index
- EEG telemetry
- Most robust sleep architecture data available. Demonstrates selective REM enhancement without sedation
- Unpublished human pilot (2022, n=18)
- 500 mcg SC twice daily × 28 days
- Not measured (subjective report: 61% noted vivid dreams)
- PSQI improved from 8.2 to 5.1 (p<0.03)
- Pittsburgh Sleep Quality Index
- Suggestive but underpowered. Dream vividness correlates with REM but doesn't confirm architecture changes
- Anecdotal reports compiled (Real Peptides client feedback, 2024–2026)
- 250–500 mcg daily (varied timing)
- Not measured (subjective: 38% report improved sleep quality)
- Reduced sleep onset latency in ~25% of reports
- Self-reported
- Valuable for hypothesis generation but cannot establish causation or rule out placebo effect
- Rodent anxiety model (Journal of Physiology, 2020)
- 5 mcg/kg daily × 21 days
- Not measured
- Normalized stress-disrupted sleep patterns (non-specific)
- Behavioral observation
- Suggests sleep benefits may be secondary to HPA axis modulation rather than direct REM effect